Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How Diabetes and Heart Failure Modulate Each Other and Condition Management
Varinder K. Randhawa, Savita Dhanvantari, Kim A. Connelly
Canadian Journal of Cardiology (2020) Vol. 37, Iss. 4, pp. 595-608
Closed Access | Times Cited: 16

Showing 16 citing articles:

Inhibition of the long non‐coding RNA ZFAS1 attenuates ferroptosis by sponging miR‐150‐5p and activates CCND2 against diabetic cardiomyopathy
Tingjuan Ni, Xingxiao Huang, Sunlei Pan, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 21, pp. 9995-10007
Open Access | Times Cited: 90
Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence
Alberto Palazzuoli, Massimo Iacoviello
Heart Failure Reviews (2022) Vol. 28, Iss. 3, pp. 585-596
Open Access | Times Cited: 50
Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac Insulin Resistance and a Potential Therapeutic Target Against Ischemic Heart Failure in Prediabetic Animals
Zhijun Meng, Zhen Zhang, Jianli Zhao, et al.
Circulation (2023) Vol. 147, Iss. 15, pp. 1162-1179
Open Access | Times Cited: 18
Molecular structure of NRG-1 protein and its impact on adult hypertension and heart failure: A new clinical Indicator diagnosis based on advanced machine learning
Qiyuan Bai, Hao Chen, Hongxu Liu, et al.
International Journal of Biological Macromolecules (2025), pp. 140955-140955
Closed Access
Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013–2021
Jimmy Gonzalez, Chintan Dave
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Lower Circulating Cell-Free Mitochondrial DNA Is Associated with Heart Failure in Type 2 Diabetes Mellitus Patients
Tetiana A. Berezina, M. P. Kopytsya, O. V. Petyunina, et al.
Cardiogenetics (2023) Vol. 13, Iss. 1, pp. 15-30
Open Access | Times Cited: 7
An Overview of Diabetic Cardiomyopathy
Abdul Quaiyoom, Ranjeet Kumar
Current Diabetes Reviews (2023) Vol. 20, Iss. 5
Closed Access | Times Cited: 5
Diabetes Mellitus and Heart Failure
Wun-Zhih Siao, Yong-Hsin Chen, Chin‐Feng Tsai, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1698-1698
Open Access | Times Cited: 8
KDM3A Inhibition Ameliorates Hyperglycemia-Mediated Myocardial Injury by Epigenetic Modulation of Nuclear Factor Kappa-B/P65
Bofang Zhang, Jing Zhang, Gen Liu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
Alexander A. Berezin, I. M. Fushtey, С. В. Павлов, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 5
Use of Digital Health Technology in Heart Failure and Diabetes: a Scoping Review
Dania Kallas, Navroop Sandhu, Christina Gandilo, et al.
Journal of Cardiovascular Translational Research (2022) Vol. 16, Iss. 3, pp. 526-540
Open Access | Times Cited: 4
Txnip promotes autophagic apoptosis in diabetic cardiomyopathy by upregulating FoxO1 and its acetylation
Yaoting Zhang, Bing Li, Yu Fu, et al.
Cellular Signalling (2024) Vol. 124, pp. 111469-111469
Closed Access
CIDEC: A Potential Factor in Diabetic Vascular Inflammation
Fangqiang Song, Huimin Zhou, Weixuan Ma, et al.
Journal of Vascular Research (2022) Vol. 59, Iss. 2, pp. 114-123
Closed Access | Times Cited: 2
Inhibition of the Long non-coding RNA ZFAS1 attenuates pathogenic ferroptosis by sponging miR-150-5p to activate CCND2 against diabetic cardiomyopathy
Tingjuan Ni, Xiaorong Chen, Xingxiao Huang, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 2
Moving Toward “Precision” Medicine: Can We Tailor Diabetes Therapy to Patients’ Differential Risks of Future Cardiovascular Disease?
Katherine Clark, Alanna A. Morris
Journal of Cardiac Failure (2022) Vol. 29, Iss. 3, pp. 255-257
Closed Access
When Ischemic Heart Failure Complicated with Diabetes Mellitus
Yuchao Zhang, Shaoping Wang
Clinical Cardiology and Cardiovascular Interventions (2021) Vol. 4, Iss. 17, pp. 01-03
Open Access
Page 1

Scroll to top